PATENT CLAIM ANALYSIS

Application Number: 15991382
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "254090"]

Abstract:
Compositions and methods for treating hyperemia and symptoms in pinguecula and pseudopteryigium are disclosed. The methods include administration of a multikinase inhibitor, an antimetabolite or a combination thereof to patients in need thereof.

Claim (Index 15):
The method of  claim 14 , wherein the multikinase inhibitor is nintedanib free base or nintedanib esylate (ethanesulfonate salt).

Metadata:
- Claim Count in Document: 38.0
- Percentile: 93.0
- Lexical Diversity: 1.24138
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15991698', '15474620', '15375820', '15700735', '12463279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8284634963738315
- 35 USC 102 Novelty (BERT): 0.6042083713044709
- Combined Prediction Score: 0.8060379838668955
- Mean Citation Score: 454.514394
- Max Citation Score: 605.0357700000002
- Similarity Product: 444.56490955790537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test